Oksana Gavrilova

Title: Oksana Gavrilova: Innovator in A1 Adenosine Receptor Agonists

Introduction

Oksana Gavrilova is a prominent inventor based in Bethesda, MD (US). She has made significant contributions to the field of pharmacology, particularly in the development of A1 adenosine receptor agonists. Her work focuses on innovative compounds that have the potential to treat various diseases and conditions.

Latest Patents

Oksana Gavrilova holds a patent for A1 adenosine receptor agonists and methods of use thereof. The patent discloses compounds of specific formulas that act as A1 adenosine receptor agonists. These compounds are designed for use in pharmaceutical compositions and are intended to induce and maintain a hypothermic and/or hypometabolic state for the treatment of mammals. The patent highlights the selectivity of these compounds to the A1 adenosine receptor, showcasing their potential therapeutic applications.

Career Highlights

Oksana Gavrilova is associated with the United States of America, as represented by the Secretary, Department of Health and Human Services. Her career is marked by her dedication to advancing medical science through innovative research and development. She has successfully navigated the complexities of patent applications, ensuring that her inventions are protected and can benefit the medical community.

Collaborations

Oksana has collaborated with notable professionals in her field, including Kenneth Alan Jacobson and Dilip K Tosh. These collaborations have further enriched her research and contributed to the advancement of her innovative work.

Conclusion

Oksana Gavrilova is a trailblazer in the field of pharmacology, with her patent on A1 adenosine receptor agonists paving the way for new treatment options. Her contributions reflect her commitment to innovation and the betterment of healthcare.